The DEA wants to make it easier to sell marijuana

… if you’re a pharmaceutical company. It was, of course, fascinating (although unsurprising) how fast Marinol was able to get moved from Schedule 1 to Schedule 3. Marinol is, after all, synthetic THC (or dronabinol) and marketed to function the same as marijuana (although its limitations can be quite severe compared to whole plant cannabis). […]